FDA Warns of Increased Failure Risk for Hintermann Ankle Replacement Device

The U.S. Food and Drug Administration has issued a safety alert regarding the Hintermann Series H3 Total Ankle Replacement System. The agency indicates a higher long-term risk of device failure, the need for revision surgery, and potential polyethylene fracture associated with this implant. Patients and healthcare providers are advised to consider alternative treatments and maintain current follow-up schedules if the device is performing adequately.